Test Code NAACD N-Acetylaspartic Acid, Canavan Disease, Random, Urine
Necessary Information
1. Patient's age and sex are required.
2. Include family history, clinical condition (asymptomatic or acute episode), diet, and drug therapy information
Specimen Required
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 10 mL
Pediatric: If insufficient collection volume, submit as much specimen as possible in a single container; the laboratory will determine if volume is sufficient for testing.
Collection Instructions:
1. Collect a random urine specimen (first morning void preferred).
2. No preservative.
Forms
Useful For
Diagnosis and monitoring of individuals with Canavan disease
Follow-up quantitation of abnormal organic acid elevations of N-acetylaspartic acid
Special Instructions
Method Name
Gas Chromatography Mass Spectrometry (GC-MS)
Reporting Name
N-acetylaspartic acid, USpecimen Type
UrineSpecimen Minimum Volume
3 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Urine | Frozen (preferred) | 90 days |
Refrigerated | 90 days | |
Ambient | 14 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
≤50.00 mmol/mol creatinine
Interpretation
When abnormal results are detected, a detailed interpretation is given including an overview of the results and of their significance; a correlation to available clinical information; elements of differential diagnosis; recommendations for additional biochemical testing and in vitro confirmatory studies (enzyme assay, molecular analysis).
Day(s) Performed
Monday
Report Available
3 to 9 daysPerforming Laboratory

CPT Code Information
83921
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
NAACD | N-acetylaspartic acid, U | 76023-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
621425 | Interpretation | 59462-2 |
621424 | N-acetylaspartic acid | 76023-1 |
621426 | Reviewed By | 18771-6 |